Head of Commercial Development UK & EU Joins the Team

By /

We are thrilled to announce that Abigail Lishman has joined our team as the Head of Commercial Development in the UK and EU.

Abigail brings a wealth of experience from business development roles in diagnostics and devices, where she played a pivotal role in driving commercial success across Europe.

With a proven track record in the diagnostics industry and a passion for innovation and improving patient outcomes, Abigail is perfectly positioned to help us accelerate our growth and reach new heights. We look forward to her leadership and fresh perspective as we continue to revolutionise cancer diagnostics.

Welcome to the team, Abigail!

About Dxcover Limited.

Dxcover is a clinical stage liquid biopsy company developing tests for the early detection of multiple solid tumor cancers, when treatment has a better chance to impact outcomes. The company pioneered Multi-Omic Spectral Analysis for the early detection of cancer by infrared spectroscopy and has generated compelling clinical data with high accuracy detection of Stage I and Stage II cancers and adenomas. Dxcover is based in Scotland, United Kingdom and recently incorporated in the US.

For further information go to https://www.dxcover.com/science

The post Head of Commercial Development UK & EU Joins the Team first appeared on Dxcover.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top